Findings May Improve Mortality Predictions for RCC Patients 
Renal and Urology News
ATLANTA?New findings may better enable clinicians to predict cancer-specific and other-cause mortality among patients who have undergone nephrectomy for renal cell carcinoma (RCC), according to a report presented at the American Urological Association ...

 

Adrenalectomy Plus Nephrectomy Linked to Reduced Survival 
Medscape
May 19, 2012 (Atlanta, Georgia) ? Overall survival is lower in patients with renal cell carcinoma who underwent radical nephrectomy with concurrent ipsilateral adrenalectomy than in patients with the ipsilateral adrenal gland left intact, according to ...

and more » 

Astellas & AVEO: Tivozanib Successfully Demonstrates the Longest Reported ... 
MarketWatch (press release)
(10) Renal cell carcinoma (RCC) accounts for approximately 90% of all kidney cancers, representing 2-3% of all cancers worldwide.(5,6) It is nearly twice as common in men as in women, mainly in adults aged 50-80 years.(11) Cancer cells grow in the ...
Astellas reports positive trial data for renal cell carcinoma drug Zenopa
Aveo kidney cancer drug more tolerated than Nexavar Chicago Tribune
Aveo Kidney Cancer Drug Shows Safety Edge in Pivotal Study Xconomy
TheStreet.com (press release)  -Pharma Times 
all 26 news articles » 

RCDB: Renal Cancer Gene Database 
7thSpace Interactive (press release)
Renal cell carcinoma or RCC is one of the common and most lethal urological cancers, with 40% of the patients succumbing to death because of metastatic progression of the disease. Treatment of metastatic RCC remains highly challenging because of its ...

 

Pfizer Provides Topline Results From Phase 3 Study Of Torisel(R) As Second ... 
MarketWatch (press release)
NEW YORK, May 15, 2012 (BUSINESS WIRE) -- Pfizer Inc announced today that the Phase 3 INTORSECT (B1771003) study, evaluating TORISEL(R) (temsirolimus) in patients with advanced renal cell carcinoma (RCC) whose disease had progressed on or after ...
Pfizer Phase III renal cell carcinoma study fails to meet primary endpoint Pharmaceutical Business Review
Pfizer's Torisel fails in Ph III advanced renal cell cancer study The Pharma Letter
Pfizer Provides Topline Results From Phase 3 Study Of Torisel® As Second-Line ... EON: Enhanced Online News (press release)
NASDAQ  -News-Medical.net  -Drug Store News 
all 23 news articles » 

Aveo sees positive safety data for kidney cancer drug 
Mass High Tech
By Lori Valigra Aveo Oncology (NASDAQ:AVEO) of Cambridge and partner Astellas Pharma Inc. (TSE:4503) of Tokyo revealed more data from the TIVO-1 Phase 3 clinical trial of tivozanib, their drug candidate for renal cell carcinoma, including positive ...
Aveo, Astellas Report Positive Data from Phase III Comparative Tivozanib Trial ... Genetic Engineering News

all 3 news articles » 

Targeted Therapies Drive the Global Renal Cell Carcinoma (RCC) Drugs Market ... 
San Francisco Chronicle (press release)
GIA announces the release of a comprehensive global report on the Kidney Cancer Drugs markets. The global market for Renal Cell Carcinoma (RCC) Drugs is forecast to reach $3.03 billion by the year 2017, driven by the growing preference for targeted ...

and more » 

Is Kidney Cancer Rare? 
dailyRx
For an uncommon cancer, a large enough population to study is necessary for doctors to make decisions on future cases. While there are well over a dozen different types of kidney cancer, a large study was launched on papillary renal cell carcinoma, ...

 

UPDATE: Cancer Genetics Plans $48.6M IPO 
GenomeWeb
The firm added in its SEC document that it entered into a collaboration this month with the Cleveland Clinic to develop a diagnostic test for renal cell carcinoma focused on validating genomic biomarkers. In connection with the agreement, ...

and more » 

Scientists identify 'critical' gene for development and spread of lung cancer 
Fox News
Besides lung cancer, MMP-10 is also suspected to play a role in colorectal, breast, prostate, ovarian and kidney cancers, as well as melanoma and renal cell carcinoma. The finding suggests drugs or compounds that inhibit MMP-10 activity could be ...

and more »